DOES SITE SPECIFIC LABELING OF SEXTANT BIOPSY CORES PREDICT THE SITE OF EXTRACAPSULAR EXTENSION IN RADICAL PROSTATECTOMY SURGICAL SPECIMEN?
- 1 October 1999
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 162 (4) , 1352-1357
- https://doi.org/10.1016/s0022-5347(05)68284-5
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- SECULAR CHANGES IN RADICAL PROSTATECTOMY UTILIZATION RATES IN OLMSTED COUNTY, MINNESOTA 1980 TO 1995Journal of Urology, 1998
- An adjustment to the 1997 estimate for new prostate cancer casesCancer, 1997
- Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional updatePublished by American Medical Association (AMA) ,1997
- Extended Followup of the Influence of Wide Excision of the Neurovascular Bundle(s) on Prognosis in Men with Clinically Localized Prostate Cancer and Extensive Capsular PerforationJournal of Urology, 1996
- Repeat Prostate Needle Biopsy: Who Needs it?Journal of Urology, 1995
- Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancerPublished by American Medical Association (AMA) ,1994
- Analysis of Risk Factors Associated with Prostate Cancer Extension to the Surgical Margin and Pelvic Node Metastasis at Radical ProstatectomyJournal of Urology, 1993
- Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screeningPublished by American Medical Association (AMA) ,1993
- The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate CancerJournal of Urology, 1993
- Screening for Prostatic Carcinoma with Prostate Specific AntigenJournal of Urology, 1992